IPO Activity Set To Spring Back As 14 Cos. Target $2B

By Chelsea Naso (May 1, 2015, 8:35 PM EDT) -- A wave of 14 companies targeting $2 billion are expected to splash onto the market during the first full week of May, putting investor appetite for life sciences to the test with a surge of 10 offerings while a master limited partnership, a real estate investment trust, a loan provider and a restaurant chain also prepare to take the plunge.

The life sciences industry is primed to steal the spotlight during the coming week, with 10 companies looking to raise about $670 million in capital.

On deck to go public is cancer treatment developers Adaptimmune Therapeutics PLC and MultiVir Inc., painkiller...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!